Share this article on:

Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation

Busch, Michael Pa,b; Pilcher, Christopher Dc; Mastro, Timothy Dd; Kaldor, Johne; Vercauteren, Gabyf; Rodriguez, Williamg; Rousseau, Christineg; Rehle, Thomas Mh; Welte, Alexi; Averill, Megan Dd; Calleja, Jesus M Garciaffor the WHO Working Group on HIV Incidence Assays

doi: 10.1097/QAD.0b013e32833f1142
Editorial Review

aBlood Systems Research Institute, USA

bDepartment of Laboratory Medicine, USA

cHIV/AIDS Division, University of California, San Francisco, California, USA

dFHI, Research Triangle Park, North Carolina, USA

eUniversity of New South Wales, Sydney, Australia

fWorld Health Organization, Geneva, Switzerland

gBill and Melinda Gates Foundation, Seattle, Washington, USA

hHuman Sciences Research Council, Cape Town, South Africa

iUniversity of the Witwatersrand and South African Centre for Epidemiological Modeling and Analysis, Johannesburg, South Africa.

Received 16 July, 2010

Accepted 28 July, 2010

Correspondence to Dr Michael P. Busch, MD, PhD, Director, Blood Systems Research Institute, Vice President, Research/Scientific Affairs, Blood Systems, Professor of Laboratory Medicine, UCSF, 270 Masonic Avenue, San Francisco, CA 94118, USA. Tel: +1 415 749 6615; fax: +1 415 407 2328; e-mail: mbusch@bloodsystems.org

© 2010 Lippincott Williams & Wilkins, Inc.